Sign Up to like & get
recommendations!
0
Published in 2025 at "Genome Medicine"
DOI: 10.1186/s13073-025-01553-2
Abstract: Neoadjuvant therapy plays an important role in the treatment of glioblastoma (GBM), but a considerable proportion of patients remain unresponsive to the combination of immune checkpoint blockade (ICB) and antiangiogenic therapy. Understanding the mechanisms underlying…
read more here.
Keywords:
col6a3 tafs;
spatial reprogramming;
glioblastoma;
vascular fibrosis ... See more keywords